ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	24/154	191/7206	1.33618957366e-12
ko04621	NOD-like receptor signaling pathway	20/154	157/7206	9.08739771967e-11
ko05164	Influenza A	20/154	167/7206	2.81996164343e-10
ko04380	Osteoclast differentiation	17/154	134/7206	2.75560656221e-09
ko04217	Necroptosis	18/154	178/7206	3.53056712427e-08
ko04658	Th1 and Th2 cell differentiation	13/154	96/7206	1.02172958079e-07
ko04064	NF-kappa B signaling pathway	13/154	96/7206	1.02172958079e-07
ko05340	Primary immunodeficiency	8/154	30/7206	1.42482953995e-07
ko04650	Natural killer cell mediated cytotoxicity	12/154	97/7206	8.80803905512e-07
ko05162	Measles	13/154	120/7206	1.42534179635e-06
ko05168	Herpes simplex infection	16/154	182/7206	1.44240898618e-06
ko04660	T cell receptor signaling pathway	13/154	124/7206	2.07416876171e-06
ko05321	Inflammatory bowel disease (IBD)	9/154	56/7206	2.36425169342e-06
ko05145	Toxoplasmosis	13/154	126/7206	2.48792657009e-06
ko05323	Rheumatoid arthritis	11/154	89/7206	2.58593237625e-06
ko05140	Leishmaniasis	10/154	75/7206	3.73474276673e-06
ko04630	Jak-STAT signaling pathway	13/154	132/7206	4.20321848869e-06
ko05160	Hepatitis C	14/154	153/7206	4.24478200073e-06
ko04620	Toll-like receptor signaling pathway	11/154	100/7206	8.19491896727e-06
ko05152	Tuberculosis	15/154	187/7206	9.70190670115e-06
ko04659	Th17 cell differentiation	11/154	106/7206	1.44080624222e-05
ko04612	Antigen processing and presentation	9/154	77/7206	3.43414922969e-05
ko04668	TNF signaling pathway	11/154	120/7206	4.65321609189e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/154	191/7206	5.33264295315e-05
ko05131	Shigellosis	9/154	82/7206	5.6959650381e-05
ko05133	Pertussis	9/154	87/7206	9.10311577316e-05
ko04062	Chemokine signaling pathway	14/154	201/7206	9.28988676152e-05
ko04672	Intestinal immune network for IgA production	6/154	37/7206	0.00011616518903
ko05161	Hepatitis B	12/154	173/7206	0.000310416083004
ko04662	B cell receptor signaling pathway	8/154	88/7206	0.00054846384352
ko04145	Phagosome	11/154	162/7206	0.00066337343025
ko05132	Salmonella infection	8/154	98/7206	0.00112187411245
ko05330	Allograft rejection	4/154	24/7206	0.00152719393154
ko04623	Cytosolic DNA-sensing pathway	5/154	41/7206	0.00168259897648
ko04622	RIG-I-like receptor signaling pathway	6/154	62/7206	0.00198051363239
ko04933	AGE-RAGE signaling pathway in diabetic complications	9/154	135/7206	0.00232464117385
ko04657	IL-17 signaling pathway	7/154	87/7206	0.00248393045117
ko05144	Malaria	5/154	45/7206	0.00256165075345
ko04666	Fc gamma R-mediated phagocytosis	8/154	122/7206	0.00446574408144
ko05134	Legionellosis	6/154	74/7206	0.0048408969416
ko04670	Leukocyte transendothelial migration	9/154	151/7206	0.00491621249923
ko05310	Asthma	3/154	17/7206	0.00522301417858
ko05166	HTLV-I infection	14/154	292/7206	0.00535278460354
ko03050	Proteasome	5/154	54/7206	0.00568689831858
ko05332	Graft-versus-host disease	3/154	18/7206	0.00617042925531
ko04610	Complement and coagulation cascades	6/154	79/7206	0.00665868898987
ko05150	Staphylococcus aureus infection	4/154	36/7206	0.00694264433581
ko04917	Prolactin signaling pathway	6/154	87/7206	0.0105294849605
ko00051	Fructose and mannose metabolism	4/154	42/7206	0.0119540023905
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/154	92/7206	0.0136361336545
ko04210	Apoptosis	9/154	180/7206	0.0147707707203
ko04142	Lysosome	8/154	151/7206	0.015361763466
ko05146	Amoebiasis	6/154	99/7206	0.0189894742576
ko05142	Chagas disease (American trypanosomiasis)	7/154	130/7206	0.0210576089337
ko05320	Autoimmune thyroid disease	3/154	29/7206	0.0232920276276
ko05416	Viral myocarditis	4/154	55/7206	0.0294640355232
ko04940	Type I diabetes mellitus	3/154	32/7206	0.0301884557279
ko05169	Epstein-Barr virus infection	9/154	206/7206	0.0430349308087
ko04640	Hematopoietic cell lineage	4/154	64/7206	0.0474546241902